Kymera Therapeutics, Inc. (KYMR) NASDAQ
73.21
+1.92(+2.69%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
73.21
+1.92(+2.69%)
Currency In USD
| Market Cap | 6.57B |
| Enterprise Value | 6.29B |
| P/E Ratio | -22.66 |
| PEG Ratio | 1.52 |
| Price/Sales Ratio | 117.01 |
| Price/Book Ratio | 4.64 |
| Enterprise/Revenue | 115.78 |
| Enterprise/EBITDA | -19.47 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -6.12 |
| Operating Margin | -6.98 |
| Return On Assets | -0.19 |
| Return On Equity | -0.25 |
| Revenue | 39.2M |
| Revenue/Share | 0.53 |
| Gross Profit | 39.2M |
| EBITDA | -303.06M |
| Net Income | -311.4M |
| Diluted EPS | -3.69 |
| Total Cash | 650.93M |
| Total Cash/Share | 6.67 |
| Total Debt | 80.47M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 10.81 |
| Book Value Per Share | 15.79 |
| 52-Week Change | 65.41 |
| 52-Week High | 103 |
| 52-Week Low | 36.65 |
| Moving Average 50 Days | 83.18 |
| Moving Average 200 Days | 71.23 |
| Average Volume | 563,012 |
| Shares Outstanding | 82.26M |
| % Held by Institutions | 114.1 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |